1 Brook I.Microbial factors leading to recurrent upper respiratory tract infections. Ped Infect Dis J. 1998; 17 (Suppl) 62-67.
2.
2. Tano K, Olofsson C, Grahn-Hakansson E, Holm SE.In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catarrhalis by alpha-hemolytic streptococci from healthy children. Int J Pediatr Otorhinolaryngol. 1999;47:49-56.
3.
3. Pichichero ME, Casey JR, Mayes T, et al. Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatr Infect Dis J2000;19:917-923.
4.
4. Pichichero ME.Controversies in the treatment of streptococcal pharyngitis. Am Fam Physician. 1990;42:1567-1576.
5.
5. Pichichero ME.Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med. 1995;25:390-403.
6.
6. Sprunt K, Redman W.Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora. Ann Intern Med. 1968;68:579-590.
7.
7. Brook I, Gober AE.Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1995;121:1405-1409.
8.
8. Roos K, Holm SE, Grahn-Hakansson E, et al. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled multicenter study. Scand J Infect Dis. 1996;28:459-462.
9.
9. Falck G, Grahn-Hakansson E, Holm SE, et al. Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol. 1999;119:944-948.
